However, patients who were obese but did not have fatty liver disease were not at increased risk of hospitalization for COVID-19, according to a study of healthy people in a U.K. database who underwent MRI assessment of liver fat markers.
Intragastric balloon therapy can be considered as a weight loss intervention in patients with obesity who have not seen success with conventional therapies, according to the American Gastroenterological Association (AGA).
A retrospective cohort study in Italy compared 10-year cumulative incidence and mortality among patients with a positive result on a fecal immunochemical test (FIT) who completed a diagnostic colonoscopy versus those who did not.
Research in the past month focused on irritable bowel syndrome (IBS) and functional dyspepsia, finding a worse disease prognosis among patients with both conditions versus IBS alone, as well as sex-based differences and an inverse association between fruit intake and functional dyspepsia symptoms.
While a 0.5-mg dose twice daily may be enough to maintain remission, patients with long-standing symptoms or extensive disease might benefit from a 1-mg dose twice daily, according to an ACP Journal Club commentary.
Nivolumab (Opdivo) is approved in combination with certain types of chemotherapy for the initial treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma.
The device uses artificial intelligence (AI) based on machine learning to assist clinicians in the real-time detection of lesions, such as polyps or suspected tumors, in the colon during a colonoscopy.